6550--Rapid Molecular Testing via Roche Diagnostics Corporation
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C26025Q0839
- Agency
- Veterans Integrated Service Network 20 Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Walla Walla, Washington 99362, United States
- Points of contact
-
- Hector D Gonzalez hector.gonzalez1@va.gov (360) 553-7632
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 is procuring rapid molecular testing supplies and services for the Jonathan M Wainwright Memorial VA Medical Center. The solicitation seeks a five-year Indefinite Delivery/Indefinite Quantity contract for a rapid molecular test system, reagents, and associated services to perform SARS CoV-2, Influenza A/B, and Strep Group A tests. The vendor must provide CLIA-waived or moderate complexity tests that can be performed on the same instrument system with a preferred run time of 30 minutes or less, along with instrument installation, validation, staff training, service, repair, and routine maintenance. The evaluation will be based on the technically acceptable offer representing the best value to the government. Quotes are due by September 12, 2025, at 5:00 PM Pacific Time, with the contract period running from October 1, 2025, to September 30, 2030.
This procurement is set aside for small businesses under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) with a size standard of 1,250 employees. No incumbent contractors are specifically mentioned in the documentation. The contract has a guaranteed minimum purchase of $500 per year and a maximum contract ceiling of $375,000 over the five-year period. The estimated annual test volumes include approximately 640 Flu tests, 280 Strep A tests, and 640 SARS CoV-2 tests. The place of performance is the VA Medical Center in Walla Walla, Washington, where the vendor will provide reagent rental services on a cost per test/cost per reportable basis along with ongoing technical support and maintenance services.
Notice text
Rapid Molecular Testing for SARS COV-2, Flu and STREP.
The purpose of this activity is to acquire Rapid Molecular Testing Supplies for the Pathology and Laboratory Medical Service at the Jonathan M Wainwright Memorial VA.
- Maintain the use of the Rapid Molecular Test System, Reagents, and Service, for testing Clinical Laboratory specimens on a reagent rental agreement (Cost Per Test/Cost Per Reportable).
- Provide, and Service for performing SARS CoV-2, Influenza A/B and Strep Group A on a base year plus four (4) option years fixed price contract.
Attachments
| File | Type | Posted |
|---|---|---|
| S02-36C26025Q0839-1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--Rapid Molecular Testing via Roche Diagnostics Corporation | Award Notice | |
| 6550--Rapid Molecular Testing via Roche Diagnostics Corporation | Solicitation | |
| 6550--Rapid Molecular Testing via Roche Diagnostics Corporation | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity